Handelsbanken USA Index Criteria A1 NOK

Index fund

1 year

Region

USA

Largest region

Medium

Risk

Cost

Morningstar

 

Yes 

Sustainability

Development

Last 5 years
( ann.)

Description

  • Fondet er et indeksfond som følger Solactive ISS ESG Screened Paris Aligned USA, med mål å gi en avkastning så nært som mulig i samsvar med avkastningen i indeksen. Indeksens formål er å gjenspeile utviklingen av aksjemarkedet i USA, med unntak av de selskapene som ikke møter bærekraftsmålene til indeksen. Fondet rapporteres som artikkel 9 i henhold til offentliggjøringsforordningen SFDR (EU-forordning 2019/2088 om bærekraftsrelaterte opplysninger i finanssektoren).

Investment horizon

  • Handelsbanken USA Index Criteria A1 NOK is a Index fund. This mutual fund type is suitable for those who plan to save for at least 6 years.

Characteristics

  • Minimum amount
  • Sharpe 3 years
  • Price/NAV

    04 Jun 2025

  • Start date
    11 Feb 2015
  • ISIN
    SE0006800157

Risk

  • Medium (4 of 7)

Morningstar rating

  • The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.

Sustainability

Costs

  • Ongoing costs

    Includes management fees of 0,20 %

  • Platform fee
  • Kickback fee
  • Annual running costs
  • Performance-based fee
  • Any transaction costs to the manager are not included in the cost overview. These are stated under cost details on the summary page before you purchase the fund. Costs for any currency exchanges are not included.

Allocation

  • Stocks 100%
    Interest 0%

Portfolio

Shows the fund's largest investments.

  • Microsoft Corp
    7.4%
  • Apple Inc
    6.5%
  • NVIDIA Corp
    6.4%
  • Meta Platforms Inc Class A
    3.3%
  • Broadcom Inc
    2.6%
  • Alphabet Inc Class A
    2.4%
  • Alphabet Inc Class C
    2.2%
  • JPMorgan Chase & Co
    1.7%
  • Berkshire Hathaway Inc Class B
    1.6%
  • Eli Lilly and Co
    1.6%